Heart & Lung: The Journal of Acute and Critical Care
Volume 37, Issue 6 , Pages 455-465 , November 2008

Predictors of smoking relapse in women with cardiovascular disease in a 30-month study: Extended analysis

  • Wen-Wen Li, RN, MS, PhD

      Affiliations

    • School of Nursing, San Francisco State University, San Francisco, California
    • Department of Community Health Systems, School of Nursing, University of California, San Francisco, California
    • Corresponding Author InformationCorresponding author: Wen-Wen Li, RN, MS, PhD, School of Nursing, San Francisco State University, 1600 Holloway Avenue, Burk Hall 383, San Francisco, CA 94132
  • ,
  • Erika S. Froelicher, RN, MPH, PhD

      Affiliations

    • Department of Physiological Nursing, School of Nursing, University of California San Francisco, San Francisco, California
    • Department of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, San Francisco, California

References 

  1. American Heart Association. Heart disease and stroke statistics—2004 update. Dallas, TX: American Heart Association; 2004;
  2. Center for Disease Prevention and Control. Reducing tobacco use: a report of the Surgeon General—executive summary. MMWR Morb Mortal Wkly Rep. 2000;49(RR-16):1–27
  3. Rigotti NA, Singer DE, Mulley AG, Thibault GE. Smoking cessation following admission to a coronary care unit. J Gen Intern Med. 1991;6:305–311
  4. Hasdai D, Garratt KN, Grill DE, et al. Predictors of smoking cessation after percutaneous coronary revascularization [see comments]. Mayo Clin Proc. 1998;73:205–209
  5. Burling TA, Singleton EG, Bigelow GE, Baile WF. Smoking following myocardial infarction: A critical review of the literature. Health Psychol. 1984;3:83–96
  6. Di Tullio M, Granata D, Taioli E, et al. Early predictors of smoking cessation after myocardial infarction. Clin Cardiol. 1991;14:809–812
  7. Johnson JL, Budz B, Mackay M, Miller C. Evaluation of a nurse-delivered smoking cessation intervention for hospitalized patients with cardiac disease. Heart Lung. 1999;28:55–64
  8. Centers for Disease Control and Prevention. Cigarette smoking among adults—United States, 2004. MMWR Morb Mortal Wkly Rep. 2005;54:1121–1124
  9. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85–e151
  10. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Washington, DC: US Department of Health and Human Services, Public Health Service; 2000;
  11. U.S. Department of Health and Human Services. Treating tobacco use and dependence: clinical practical guideline. Washington, DC: Government Printing Office; 2000;
  12. United States Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Atlanta, GA: United States Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004;
  13. Froelicher ES, Christopherson DJ. Women's initiative for nonsmoking (WINS) I: design and methods. Heart Lung. 2000;29:429–437
  14. Froelicher ES, Christopherson DJ, Miller NH, Martin K. Women's initiative for nonsmoking (WINS) IV: description of 277 women smokers hospitalized with cardiovascular disease. Heart Lung. 2002;31:3–14
  15. Froelicher ES, Kozuki Y. Theoretical applications of smoking cessation interventions to individuals with medical conditions: women's initiative for nonsmoking (WINS)-part III. Int J Nurs Stud. 2002;39:1–15
  16. Froelicher ES, Sohn M, Max W, Bacchetti P. Women's Initiative for Nonsmoking-VII: evaluation of health service utilization and costs among women smokers with cardiovascular disease. J Cardiopulm Rehabil. 2004;24:218–228
  17. Froelicher ES, Li WW, Mahrer-Imhof R, Christopherson D, Stewart AL. Women's initiative for non-smoking (WINS) VI: reliability and validity of health and psychosocial measures in women smokers with cardiovascular disease. Heart Lung. 2004;33:162–175
  18. Martin K, Froelicher ES, Miller NH. Women's initiative for nonsmoking (WINS) II: the intervention. Heart Lung. 2000;29:438–445
  19. Mahrer-Imhof R, Froelicher ES, Li WW, Parker KM, Benowitz N. Women's Initiative for Nonsmoking (WINS V): under-use of nicotine replacement therapy. Heart Lung. 2002;31:368–373
  20. Sivarajan Froelicher ES, Miller NH, Christopherson DJ, et al. High rates of sustained smoking cessation in women hospitalized with cardiovascular disease: the Women's Initiative for Nonsmoking (WINS). Circulation. 2004;109:587–593
  21. Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care. 1988;26:775–789
  22. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–396
  23. Stewart AL, King AC, Killen JD, Ritter PL. Does smoking cessation improve health-related quality-of-life. Ann Behav Med. 1995;17:331–338
  24. Glassman AH, Helzer JE, Covey LS, et al. Smoking, smoking cessation, and major depression [see comments]. JAMA. 1990;264:1546–1549
  25. Bandura A. Social learning theory. Englewood Cliffs, NJ: Prentice-Hall; 1977;
  26. Froelicher ES, Kozuki Y. Theoretical application of smoking cessation interventions to individuals with medical conditions: Women's Initiative for Nonsmoking III. Int J Nurs Stud. 2002;39:1–15
  27. An active partnership for the health of your heart. Dallas TX: American Heart Association; 1990;
  28. Sherbourne C, Stewart A, Wells AL. Role functioning measures. In:  Stewart AL,  Ware JE editor. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham, NC: Duke University Press; 1992;p. 205–219
  29. Condiotte MM, Lichtenstein E. Self-efficacy and relapse in smoking cessation programs. J Consult Clin Psychol. 1981;49:648–658
  30. Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE. Regression methods in biostatistics: linear, logistic, survival, and repeated measures models. New York, NY: Springer; 2005;
  31. StataCorp LP. Getting started with STATA for Windows. College Station, TX: STATA Press; 2005;
  32. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79:340–349
  33. Rigotti NA, Munafo SR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2007;CD001837
  34. Chouinard MC, Robichaud-Ekstrand S. The effectiveness of a nursing inpatient smoking cessation program in individuals with cardiovascular disease. Nurs Res. 2005;54:243–254
  35. Boardman T, Catley D, Mayo MS, Ahluwalia JS. Self-efficacy and motivation to quit during participation in a smoking cessation program. Int J Behav Med. 2005;12:266–272
  36. Borrelli B, Marcus BH, Clark MM, Bock BC, King TK, Roberts M. History of depression and subsyndromal depression in women smokers. Addict Behav. 1999;24:781–794
  37. Thorndike AN, Regan S, McKool K, et al. Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease. Arch Intern Med. 2008;168:186–191
  38. Costa e Silva JA, Saraceno B. A focus on women: Division of Mental Health and Prevention of Substance Abuse. Geneva, Switzerland: World Health Organization; 1997;
  39. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report (The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives). JAMA. 2000;283:3244–3254

 This study was funded by grant No. R01H150749 (08-01-96 to 06-30-02) from the National Institutes of Health National Heart, Lung, and Blood Institute.

PII: S0147-9563(08)00137-4

doi: 10.1016/j.hrtlng.2008.07.005

Heart & Lung: The Journal of Acute and Critical Care
Volume 37, Issue 6 , Pages 455-465 , November 2008